82 FR 25804 - National Institute of General Medical Sciences; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 106 (June 5, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 106 (June 5, 2017)
| Page Range | 25804-25804 | |
| FR Document | 2017-11498 |
[Federal Register Volume 82, Number 106 (Monday, June 5, 2017)] [Notices] [Page 25804] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-11498] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIGMS Initial Review Group; Training and Workforce Development Subcommittee--D; To review R25 Bridges to Baccalaureate and K12 IRACDA Grant applications. Date: June 22-23, 2017. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Palomar, 2121 P Street NW., Washington, DC 20037. Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18C, Bethesda, MD 20892, 301-594-2771, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: May 30, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-11498 Filed 6-2-17; 8:45 am] BILLING CODE 4140-01-P
![25804 Federal Register / Vol. 82, No. 106 / Monday, June 5, 2017 / Notices
Name of Committee: National Institute of applications, the disclosure of which Property Office on or before June 20,
Diabetes and Digestive and Kidney Diseases would constitute a clearly unwarranted 2017 will be considered.
Special Emphasis Panel; NIDDK P01 Review. invasion of personal privacy. ADDRESSES: Requests for copies of the
Date: July 18, 2017.
Time: 4:00 p.m.to 6:30 p.m. Name of Committee: NIGMS Initial Review patent application, inquiries, and
Agenda: To review and evaluate grant Group; Training and Workforce Development comments relating to the contemplated
applications. Subcommittee—D; To review R25 Bridges to Exclusive Commercialization Patent
Place: National Institutes of Health, Two Baccalaureate and K12 IRACDA Grant License should be directed to: Peter
Democracy Plaza, 6707 Democracy applications. Soukas, Technology Transfer and Patent
Boulevard, Bethesda, MD 20892 (Telephone Date: June 22–23, 2017. Specialist, Technology Transfer and
Conference Call). Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
Intellectual Property Office, National
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch, applications. Institute of Allergy and Infectious
DEA, NIDDK, National Institutes of Health, Place: Hotel Palomar, 2121 P Street NW., Diseases, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Washington, DC 20037. 5601 Fishers Lane, Suite 6D, Rockville,
Bethesda, MD 20892–5452, (301) 594–4719, Contact Person: Rebecca H. Johnson, Ph.D., MD 20852–9804; Email: ps193c@
guox@extra.niddk.nih.gov. Scientific Review Officer, Office of Scientific nih.gov; Telephone: (301) 594–8730;
Name of Committee: National Institute of Review, National Institute of General Medical Facsimile: (240) 627–3117.
Diabetes and Digestive and Kidney Diseases Sciences, National Institutes of Health,
SUPPLEMENTARY INFORMATION:
Special Emphasis Panel; Program Project on Natcher Building, Room 3AN18C, Bethesda,
Mucosal Immunology. MD 20892, 301–594–2771, johnsonrh@ Intellectual Property
Date: July 25, 2017. nigms.nih.gov.
E–357–2001/0,1, Pletnev et al.,
Time: 12:00 p.m. to 3:00 p.m. (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Program Nos. 93.375, Minority Biomedical
‘‘Construction of West Nile Virus and
applications. Research Support; 93.821, Cell Biology and Dengue Virus Chimeras for use in a Live
Place: National Institutes of Health, Two Biophysics Research; 93.859, Pharmacology, Virus Vaccine to Prevent Disease Cause
Democracy Plaza, 6707 Democracy Physiology, and Biological Chemistry by West Nile Virus,’’ U.S. Provisional
Boulevard, Bethesda, MD 20892 (Telephone Research; 93.862, Genetics and Patent Application Number 60/347,281,
Conference Call). Developmental Biology Research; 93.88, filed January 10, 2002, PCT Patent
Contact Person: Maria E. Davila-Bloom, Minority Access to Research Careers; 93.96, Application Number PCT/US2003/
Ph.D., Scientific Review Officer, Review Special Minority Initiatives; 93.859, 00594, filed January 9, 2003, U.S. Patent
Branch, DEA, NIDDK, National Institutes of Biomedical Research and Research Training,
Health, Room 7017, 6707 Democracy Application Number 10/871,775 filed
National Institutes of Health, HHS)
Boulevard, Bethesda, MD 20892–5452, (301) June 18, 2004 (now U.S. Patent Number
594–7637, davila-bloomm@ Dated: May 30, 2017. 8,778,671), U.S. Patent Application
extra.niddk.nih.gov. David Clary, Number 14/305,572, filed June 16, 2014,
(Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory European Patent Application Number
Program Nos. 93.847, Diabetes, Committee Policy. 03729602.7, filed January 9, 2003,
Endocrinology and Metabolic Research; [FR Doc. 2017–11498 Filed 6–2–17; 8:45 am] Israeli Patent Application Number
93.848, Digestive Diseases and Nutrition BILLING CODE 4140–01–P 162949, filed January 9, 2003 (now
Research; 93.849, Kidney Diseases, Urology Israeli Patent Number 162949),
and Hematology Research, National Institutes Canadian Patent Application Number
of Health, HHS)
DEPARTMENT OF HEALTH AND 2472468, filed January 9, 2003 (now
Dated: May 30, 2017. HUMAN SERVICES Canadian Patent Number 2472468),
David Clary, Australian Patent Application Number
Program Analyst, Office of Federal Advisory National Institutes of Health 2003216046, filed January 9, 2003 (now
Committee Policy. Australian Patent Number 2003216046),
Prospective Grant of Exclusive Patent
[FR Doc. 2017–11495 Filed 6–2–17; 8:45 am] Japanese Patent Application Number
License: Production of Attenuated
BILLING CODE 4140–01–P 2003–559545, filed January 9, 2003
West Nile Virus Vaccines
(now Japanese Patent Number 4580650),
AGENCY: National Institutes of Health, Australian Patent Application Number
DEPARTMENT OF HEALTH AND Department of Health and Human 2008203442 filed July 31, 2008 (now
HUMAN SERVICES Services. Australian Patent Number 2008203442),
ACTION: Notice. Israeli Patent Application Number
National Institutes of Health 209342, filed January 9, 2003 (now
SUMMARY: The National Institute of Israeli Patent Number 209342),
National Institute of General Medical Allergy and Infectious Diseases, an European Patent Application Number
Sciences; Notice of Closed Meeting institute of the National Institutes of 11000126.0, filed January 9, 2003 (now
Pursuant to section 10(d) of the Health, Department of Health and European Patent Number 2339011,
Federal Advisory Committee Act, as Human Services, is contemplating the validated in Belgium, Great Britain, the
amended (5 U.S.C. App.), notice is grant of an Exclusive Commercialization Netherlands, Norway, Germany,
hereby given of the following meeting. Patent License to practice the inventions Denmark and France), Australian Patent
The meeting will be closed to the embodied in the Patents and Patent Application Number 2011250694, filed
Applications listed in the Summary
asabaliauskas on DSKBBXCHB2PROD with NOTICES
public in accordance with the November 10, 2011 (now Australian
provisions set forth in sections Information section of this notice to the Patent Number 2011250694), Australian
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., International Medica Foundation Patent Application Number
as amended. The grant applications and located in Shoreview, Minnesota, U.S.A. 2013213749, filed August 9, 2013,
the discussions could disclose DATES: Only written comments and/or European Patent Application Number
confidential trade secrets or commercial applications for a license which are 15163537.2, filed April 14, 2015, and
property such as patentable material, received by the National Institute of Canadian Patent Application Number
and personal information concerning Allergy and Infectious Diseases’ 2903126, filed August 27, 2015, and
individuals associated with the grant Technology Transfer and Intellectual U.S. and foreign patent applications
VerDate Sep<11>2014 17:31 Jun 02, 2017 Jkt 241001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1](https://thefederalregister.org/doc/82_FR_25910/page/1.svg)
Document Created: 2018-11-14 10:00:52
Document Modified: 2018-11-14 10:00:52
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 22-23, 2017. | |
| FR Citation | 82 FR 25804 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR